Health Sciences Stocks List

Health Sciences Stocks Recent News

Date Stock Title
May 23 AKAN Akanda shares fall 24% following 1-for-40 reverse stock split
May 23 AKAN Nasdaq Surges Over 100 Points; Nvidia Posts Upbeat Q1 Results
May 22 AMRX Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California
May 22 ARCT Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines
May 21 AKAN Akanda announces 1-for-40 reverse stock split
May 21 AKAN Akanda Announces Stock Consolidation
May 21 AFYA 3 US Growth Companies With Insider Ownership As High As 27%
May 20 AMRX Insider Sale: Director Deborah Autor Sells 38,000 Shares of Amneal Pharmaceuticals Inc (AMRX)
May 20 ACB Easy-To-Trade Cannabis Stocks: Insights Into How Trading Activity Affects These Investments
May 20 AFYA Afya Limited (the "Company") Notice of Annual General Meeting of the Company
May 20 ACB Cannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red?
May 20 AKAN Akanda Announces Closing of Subsequent Registered Direct Offering
May 20 ARCT Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics’ COVID-19 Vaccine
May 20 ACB Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates
May 20 ALLR Allarity Therapeutics Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
May 20 ACB Is Aurora Cannabis Stock a Buy?
Health Sciences

The following outline is provided as an overview of and topical guide to health sciences:
Health sciences – are those sciences which focus on health, or health care, as core parts of their subject matter. Because these two subject matter relate to multiple academic disciplines, both STEM disciplines as well as emerging patient safety disciplines (such as social care research) are relevant to current health scientific knowledge.
Health sciences knowledge bases are currently diverse, with intellectual foundations which are sometimes mutually-inconsistent. There is currently an existing bias in the field, towards high valuation of knowledge deriving from controlling views on human agency (as epitomized by the epistemological basis of Randomized Control Trial designs); compare this against the more naturalistic views on human agency taken by research based on Ethnography for example).

Browse All Tags